Electroacupuncture for intensive care patients with serious lung failure
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether adding electroacupuncture (a treatment using gentle electrical pulses on thin needles) to standard care can help people with severe lung failure or sepsis recover faster. It is designed for ICU patients who are on a breathing machine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- You are in the intensive care unit (ICU) and expected to stay for more than 7 days
- You are on a breathing machine for more than 48 hours
- You have been diagnosed with sepsis or acute respiratory distress syndrome
- You are not pregnant, do not have serious underlying diseases, and are not allergic to needles
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether gentle electrical stimulation through thin needles placed in the lower legs (electroacupuncture) can help patients fight sepsis in the ICU. It aims to see if this treatment reduces organ damage and speeds recovery.
This study tests whether acupuncture can help people at high risk for sepsis, a serious infection that can lead to organ failure. If you’re 18 or older, have had a sepsis order set put in within the last two days, and are not yet in the ICU, you may be able to join.
This trial tests a non-invasive ear stimulation device (taVNS) as an extra treatment for sepsis in the ICU. It may help reduce inflammation and improve recovery.
This trial tests if adding acupuncture to standard immunotherapy and chemotherapy helps people with advanced lung cancer. It is for those who have not had treatment before and whose tumors have low PD-L1 levels.
This study tests whether adding electroacupuncture at a specific point on the leg (called Zusanli) can help people with lung cancer who are getting chemotherapy and immunotherapy before surgery. It might reduce side effects and improve response to treatment.
This trial tests whether adding electroacupuncture to a PD-1 inhibitor (a type of immunotherapy) can help people with advanced non-small cell lung cancer who have limited activity levels. It may improve treatment response and quality of life.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.